Advertisement
Screener

HYPERION DEFI, INC. (HYPD) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

1.9 / 5 stars · 19/50 Roast Me

HYPERION DEFI, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number

HYPERION DEFI, INC. (HYPD) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 1.65 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-08-13

  • 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.65M shares.
  • 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.45M shares.
  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.54M shares.
  • 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.62M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, NumberShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed
2026-06-301.65M shares
10-Q · filed 2026-08-13
2026-03-311.45M shares
10-Q · filed 2026-05-15
2025-12-311.54M shares
10-Q · filed 2026-08-13
2025-09-301.62M shares
10-Q · filed 2025-11-14
2025-06-30288.00K shares
10-Q · filed 2025-08-13
2025-03-31244.61K shares
10-Q · filed 2025-05-19
2024-12-314.61K shares
10-K · filed 2026-03-30
2024-09-30368.89K shares
10-Q · filed 2024-11-12
2024-06-30368.89K shares
10-Q · filed 2024-08-14
2024-03-31106.02K shares
10-Q · filed 2024-05-15
2023-12-311.32K shares
10-K · filed 2025-04-15
106.02K shares
10-K · filed 2024-03-18
2023-09-3086.20K shares
10-Q · filed 2023-11-13
2023-06-3086.20K shares
10-Q · filed 2023-08-11
2023-03-31150.58K shares
10-Q · filed 2023-05-12
2022-12-31172.80K shares
10-K · filed 2024-03-18
2022-09-30172.80K shares
10-Q · filed 2022-11-14
2022-06-30111.11K shares
10-Q · filed 2022-08-11
2022-03-3148.74K shares
10-Q · filed 2022-05-13
2021-12-3141.78K shares
10-K · filed 2023-03-31
2020-12-31104.08K shares
10-K · filed 2022-03-30
2017-12-3161.88K shares
10-K · filed 2018-04-02
2016-12-310.00 shares
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76